| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Michael E. Castagna
Also a director
Chief Executive Officer and Director
|
49 | Not stated | $9,300,485 | |
|
Christopher B. Prentiss
Chief Financial Officer
|
50 |
Since 2024
2 years
|
$2,886,799 | |
|
Ajay Ahuja
Executive Vice President and Chief Medical Officer
|
56 |
Since 2025
1 year
|
Not reported | |
|
Stuart A. Tross
Chief People & Workpl Officer
Title from the Form 4 dated Jul 15, 2026
|
59 | Not stated | $2,945,695 | |
|
Dominic Marasco
President, Endocrine Business Unit
|
53 |
Since 2025
1 year
|
$6,980,472 | |
|
Sanjay Singh
Executive Vice President, Technical Operations
|
59 |
Since 2022
4 years
|
Not reported | |
|
David B. Thomson
EVP Genl Counsel & Secretary
Title from the Form 4 dated Jul 15, 2026
|
59 | Not stated | $3,155,248 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
The proxy filed Apr 7, 2026 states there were none.
Read it in the proxyLoading...